• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [94 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 National Institute for Health and Care Excellence (NICE) Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma. NICE technology appraisal guidance 985
2024 National Evidence-based Healthcare Collaborating Agency (NECA) [Resuscitative endovascular balloon occlusion of the aorta]
2024 NIHR Health and Social Care Delivery Program The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT
2023 NIHR Health Technology Assessment programme Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [UAE and MRgFUS versus myoma enucleation - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus]
2023 National Institute for Health and Care Excellence (NICE) Middle meningeal artery embolisation for chronic subdural haematomas. NICE interventional procedures guidance 779
2023 Penn Medicine Center for Evidence-based Practice (CEP) Embolization vs. conservative management for spontaneous abdominal or pelvic hemorrhage
2023 National Institute for Health and Care Excellence (NICE) Percutaneous thoracic duct embolisation for persistent chyle leak. NICE interventional procedures guidance 755
2023 National Institute for Health and Care Excellence (NICE) Transvenous obliteration for gastric varices. NICE interventional procedures guidance 751
2023 Canary Health Service [Genicular artery embolization for the treatment of knee osteoarthritis]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Embolization or sclerotherapy of pelvic veins in pelvic congestion syndrome]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Hepatic and portal vein embolisation prior to major hepatectomy
2022 NIHR Health Technology Assessment programme Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Hepatic and portal vein embolization prior to major hepatectomy
2021 Canadian Agency for Drugs and Technologies in Health (CADTH) Yttrium-90 microspheres for intermediate- or advanced-stage hepatocellular carcinoma
2021 National Institute for Health and Care Excellence (NICE) Genicular artery embolisation for pain from knee osteoarthritis. NICE interventional procedures guidance 708
2021 Ontario Health Prostatic artery embolization for benign prostatic hyperplasia
2020 Malaysian Health Technology Assessment (MaHTAS) Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2020 National Institute for Health and Care Excellence (NICE) Selective internal radiation therapy for unresectable colorectal metastases in the liver. NICE interventional procedures guidance 672
2019 Institute for Clinical Effectiveness and Health Policy (IECS) [Pelvic vein embolization or sclerotherapy in pelvic congestion syndrome]
2018 National Institute for Health and Care Excellence (NICE) Superior rectal artery embolisation for haemorrhoids. NICE interventional procedures guidance 627
2018 National Institute for Health and Care Excellence (NICE) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 611
2018 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Prostate artery embolisation: poor design and reporting impact the value of current systematic reviews
2017 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prostate artery embolisation for benign prostatic hyperplasia
2017 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Prostate artery embolisation for benign prostatic hyperplasia
2017 Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids
2017 HAYES, Inc. Flow diverter devices for intracranial aneurysms: a review of reviews
2017 Institute for Clinical Effectiveness and Health Policy (IECS) [Pelvic vein embolization or sclerotherapy in pelvic congestion syndrome]
2016 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Retrograde endovascular balloon occlusion of the aorta (REBOA)
2016 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) SureFire Precision Chemoembolization Infusion system keeps drugs within liver tumours
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Radioembolization and chemoembolization with drug-eluting microspheres for the treatment of liver tumors
2016 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2016 NIHR Health Technology Assessment programme The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis and treatment effectiveness
2015 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve blocking and gastric artery embolisation for obesity
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endovascular embolisation of intracranial aneurysms with Flow Diverter
2015 Scottish Health Technologies Group (SHTG) Magnetic resonance guided focused ultrasound surgery (MRgFUS) for the treatment of uterine fibroids
2014 HAYES, Inc. Onyx liquid embolic system (Onyx HD-500) (Covidien / ev3 Neurovascular) for treatment of cerebral aneurysms
2014 National Institute for Health and Care Excellence (NICE) Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula. NICE interventional procedures guidance 507
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Implantation of a permanent embolic protection in patients with non-valvular attrial fibrillation in left auricular appendage]
2014 HAYES, Inc. Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer
2014 HAYES, Inc. Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer as a bridge to transplantation or surgery
2013 HAYES, Inc. Transarterial embolization with embozene microspheres (CeloNova BioSciences Inc.) for treatment of hepatocellular carcinoma and other liver tumors
2013 National Institute for Health and Care Excellence (NICE) Uterine artery embolisation for treating adenomyosis. NICE interventional procedures guidance 473
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Chemoembolization and radioembolization for the treatment of liver metastases]
2012 HAYES, Inc. Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC)
2012 National Institute for Health and Care Excellence (NICE) Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms. NICE medical technologies guidance 10
2012 HAYES, Inc. Transarterial chemoembolization plus radiofrequency ablation for liver cancer
2012 Agency for Healthcare Research and Quality (AHRQ) Local hepatic therapies for metastases to the liver from unresectable colorectal cancer
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Uterine artery embolization in patients aiming to preserve the uterus]
2012 HAYES, Inc. Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Uterine artery embolisation – an alternative treatment for symptomatic uterine fibroids]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Pipeline embolization device]
2011 HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011 HAYES, Inc. Percutaneous transcatheter coil embolization for Pelvic Congestion Syndrome (PCS)
2011 HAYES, Inc. Pipeline embolization device (ev3 Inc.) for treatment of intracranial aneurysms
2011 HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2010 HTA Database, Centre for Reviews and Dissemination, University of York (CRD) Transarterial chemoembolization for palliation of unresectable liver metastases from colorectal cancer (Protocol for a systematic review)
2010 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Cerecyte (bioactive) coils for the treatment of intracranial aneurysms
2010 Institute for Clinical Effectiveness and Health Policy (IECS) Chemoembolization of hepatocellular carcinoma with drug eluting beads (DC Beads)
2010 National Institute for Health and Care Excellence (NICE) Uterine artery embolisation for fibroids. NICE interventional procedures guidance 367
2009 Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009 HAYES, Inc. Uterine artery embolization
2009 NIHR Health Technology Assessment programme Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2008 National Institute for Health and Care Excellence (NICE) Endoaortic balloon occlusion for cardiac surgery. NICE interventional procedures guidance 261
2008 NIHR Health Technology Assessment programme A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study
2008 NIHR Health Technology Assessment programme Treatment for fibroids: Uterine Artery Embolisation (UAE) or hysterectomy (HOPEFUL) - Primary Research (e.g. trial)
2008 The Netherlands Organisation for Health Research and Development (ZonMw) [Conventional Or Magnetic resonance angiography after Endovascular Treatment of intracranial aneurysms (COMET)]
2007 HAYES, Inc. ExAblate 2000 system (InSightec Ltd.) for ablation of uterine fibroids
2006 HAYES, Inc. Endovascular therapy for intracranial aneurysms
2006 Adelaide Health Technology Assessment (AHTA) Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2006 Medical Advisory Secretariat (MAS) Coil embolization for intracranial aneurysms: an evidence-based analysis
2005 Blue Cross Blue Shield Association (BCBS) Magnetic resonance-guided focused ultrasound therapy for symptomatic uterine fibroids
2005 HAYES, Inc. Uterine artery embolization for treatment of fibroids
2005 National Institute for Health and Care Excellence (NICE) Coil embolisation of ruptured intracranial aneurysms. NICE interventional procedures guidance 106
2005 National Institute for Health and Care Excellence (NICE) Coil embolisation of unruptured intracranial aneurysms. NICE interventional procedures guidance 105
2005 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Embolization in the treatment of uterine myoma]
2004 HAYES, Inc. Endovascular therapy for intracranial aneurysms
2004 Institute for Clinical Effectiveness and Health Policy (IECS) Coil embolization vs conventional surgery for the management of brain aneurysms
2004 Medical Advisory Secretariat (MAS) Coil embolization for intracranial aneurysms
2003 Wessex Institute for Health Research and Development (WIHRD) Coil embolisation of ruptured or unruptured intracranial aneurysms
2003 Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003 HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003 HAYES, Inc. Endoluminal radiofrequency ablation for varicose veins of the leg
2003 Institute for Clinical Systems Improvement (ICSI) Uterine artery embolization for uterine fibroids
2002 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2002 Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Embolization of uterine fibroids - Early Warning on New Health Technology]
2002 HAYES, Inc. Chemoembolization for primary liver cancer
2002 HAYES, Inc. Endovascular therapy for intracranial aneurysms
2001 ECRI Uterine fibroid embolization for the treatment of fibroids
2000 Alberta Heritage Foundation for Medical Research (AHFMR) Chemoembolization treatment for colorectal metastases to the liver
2000 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of endovascular coil treatment of intracranial aneurysms]